文献速递多重用药老年慢病共病管理认知障碍与谵妄

65岁及以上人群他汀不依从与停药相关因素的系统综述与荟萃分析

A Systematic Review and Meta-analysis of the Factors Associated With Nonadherence and Discontinuation of Statins Among People Aged ≥65 Years.
PubMed 文献 · J Gerontol A Biol Sci Med Sci · 2018-01-01

不依从相关因素包括黑种人/非白种人、女性、现吸烟、较高共付费用、新使用者、初级预防等;停药相关因素包括较低收入、现吸烟、较高共付费用、用药数量多、痴呆、癌症、呼吸系统疾病、初级预防等。结论提示针对可改变的经济社会障碍、风险认知及多重用药的干预可能改善老年他汀使用。

要点

  • 黑种人/非白种人、女性、现吸烟、较高共付费用、新使用者、初级预防与不依从风险升高相关。
  • 较低收入、较高共付费用、用药数量多、痴呆、癌症、呼吸系统疾病、初级预防与停药风险升高相关。
  • 针对经济与社会障碍、患者风险认知及多重用药的干预可能改善老年他汀使用。

核心结论

  • 针对可改变的经济与社会障碍、患者对疾病风险的认知以及多重用药的干预,可能改善老年人群的他汀使用。

研究设计与样本

  • 系统综述检索截至2016年12月12日的英文文献,纳入报告65岁及以上人群他汀不依从和/或停药相关因素的文章,采用随机效应荟萃分析合并数据。

主要发现

  • 与不依从风险升高相关的因素包括黑种人/非白种人(OR 1.66,95%CI 1.39-1.98)、女性(OR 1.08,95%CI 1.03-1.13)、现吸烟(OR 1.12,95%CI 1.03-1.21)、较高共付费用(OR 1.38,95%CI 1.25-1.52)、新使用者(OR 1.58,95%CI 1.21-2.07)。
  • 不依从风险升高还与较少并发心血管药物数量(OR 1.08,95%CI 1.06-1.09)、初级预防(OR 1.49,95%CI 1.40-1.59)、呼吸系统疾病(OR 1.17,95%CI 1.12-1.23)、抑郁(OR 1.11,95%CI 1.06-1.16)及无肾脏疾病(OR 1.09,95%CI 1.04-1.14)相关。
  • 与停药风险升高相关的因素包括较低收入(OR 1.20,95%CI 1.06-1.36)、现吸烟(OR 1.14,95%CI 1.06-1.23)、较高共付费用(OR 1.61,95%CI 1.53-1.70)、用药数量较多(OR 1.04,95%CI 1.01-1.06)、痴呆(OR 1.18,95%CI 1.02-1.36)。
  • 停药风险升高还与癌症(OR 1.22,95%CI 1.11-1.33)、呼吸系统疾病(OR 1.19,95%CI 1.05-1.34)、初级预防(OR 1.66,95%CI 1.24-2.22)、无高血压(OR 1.13,95%CI 1.07-1.20)及无糖尿病(OR 1.09,95%CI 1.04-1.15)相关。

临床怎么用

  • 对老年他汀使用者应关注黑种人/非白种人、女性、现吸烟、新使用者及初级预防人群的不依从风险。
  • 对较低收入、较高共付费用、多重用药、痴呆、癌症或呼吸系统疾病的老年患者应警惕停药风险。
  • 可针对经济与社会障碍、患者风险认知及多重用药设计干预,以改善老年人群他汀使用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Older individuals (aged ≥65 years) are commonly prescribed statins but may experience a range of barriers in adhering to therapy. The factors associated with poor statin adherence and/or discontinuation among this population have not been comprehensively reviewed. METHODS: We conducted a systematic review to identify English articles published through December 12, 2016 that reported factors associated with nonadherence and/or discontinuation of statins among older persons. Data were pooled via random-effects meta-analysis techniques. RESULTS: Forty-five articles reporting data from more than 1.8 million older statin users from 13 countries were included. The factors associated with increased statin nonadherence were black/non-white race (odds ratio [OR] 1.66, 95% confidence interval [CI] 1.39-1.98), female gender (OR 1.08, 95% CI 1.03-1.13), current smoker (OR 1.12, 95% CI 1.03-1.21), higher copayments (OR 1.38, 95% CI 1.25-1.52), new user (OR 1.58, 95% CI 1.21-2.07), lower number of concurrent cardiovascular medications (OR 1.08, 95% CI 1.06-1.09), primary prevention (OR 1.49, 95% CI 1.40-1.59), having respiratory disorders (OR 1.17, 95% CI 1.12-1.23) or depression (OR 1.11, 95% CI 1.06-1.16), and not having renal disease (OR 1.09, 95% CI 1.04-1.14). The factors associated with increased statin discontinuation were lower income status (OR 1.20, 95% CI 1.06-1.36), current smoker (OR 1.14, 95% CI 1.06-1.23), higher copayment (OR 1.61, 95% CI 1.53-1.70), higher number of medications (OR 1.04, 95% CI 1.01-1.06), presence of dementia (OR 1.18, 95% CI 1.02-1.36), cancer (OR 1.22, 95% CI 1.11-1.33) or respiratory disorders (OR 1.19, 95% CI 1.05-1.34), primary prevention (OR 1.66, 95% CI 1.24-2.22), and not having hypertension (OR 1.13, 95% CI 1.07-1.20) or diabetes (OR 1.09, 95% CI 1.04-1.15). CONCLUSION: Interventions that target potentially modifiable factors including financial and social barriers, patients' perceptions about disease risk as well as polypharmacy may improve statin use in the older population.

来源:J Gerontol A Biol Sci Med Sci,查看原文。版权归原作者所有。

引用

  1. Ofori-Asenso R, Jakhu A, Curtis AJ, et al. A Systematic Review and Meta-analysis of the Factors Associated With Nonadherence and Discontinuation of Statins Among People Aged ≥65 Years. J Gerontol A Biol Sci Med Sci. 2018. PMID: 29360935. doi:10.1093/gerona/glx256

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。